{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:52:32Z","timestamp":1792705952496,"version":"4.5.0"},"reference-count":130,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2016,12,16]],"date-time":"2016-12-16T00:00:00Z","timestamp":1481846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>The effectiveness of medications for PTSD in general has been well studied, but the effectiveness of medicatio.ns prescribed specifically for post-traumatic stress disorder (PTSD) nightmares is less well known. This retrospective chart review examined the efficacy of various medications used in actual treatment of PTSD nightmares at one Veteran Affairs Hospital. Records at the Salem, VA Veterans Affairs Medical Center (VAMC) were examined from 2009 to 2013 to check for the efficacy of actual treatments used in comparis.on with treatments suggested in three main review articles. The final sample consisted of 327 patients and 478 separate medication trials involving 21 individual medications plus 13 different medication combinations. The three most frequently utilized medications were prazosin (107 trials), risperidone (81 trials), and quetiapine (72 trials). Five medications had 20 or more trials with successful results (partial to full nightmare cessation) in &gt;50% of trials: risperidone (77%, 1.0\u20136.0 mg), clonidine (63%, 0.1\u20132.0 mg), quetiapine (50%, 12.5\u2013800.0 mg), mirtazapine (50%; 7.5\u201330.0 mg), and terazosin (64%, 50.0\u2013300.0 mg). Notably, olanzapine (2.5\u201310.0) was successful (full remission) in all five prescription trials in five separate patients. Based on the clinical results, the use of risperidone, clonidine, terazosin, and olanzapine warrants additional investigation in clinically controlled trials as medications prescribed specifically for PTSD nightmares.<\/jats:p>","DOI":"10.3390\/jcm5120117","type":"journal-article","created":{"date-parts":[[2016,12,16]],"date-time":"2016-12-16T10:55:28Z","timestamp":1481885728000},"page":"117","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Treatment of Post-Traumatic Stress Disorder Nightmares at a Veterans Affairs Medical Center"],"prefix":"10.3390","volume":"5","author":[{"given":"Mark","family":"Detweiler","sequence":"first","affiliation":[{"name":"Staff Psychiatrist, Veterans Affairs Medical Center, Salem, VA 24153, USA"},{"name":"Department Psychiatry, Edward via College of Osteopathic Medicine, Blacksburg, VA 24060, USA"},{"name":"Virginia Tech-Carilion Clinic Psychiatry Residency Program, Roanoke, VA 24014, USA"},{"name":"Geriatric Research Group, Veterans Affairs Medical Center, Salem, VA 24153, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhuvaneshwar","family":"Pagadala","sequence":"additional","affiliation":[{"name":"Virginia Tech-Carilion Clinic Psychiatry Residency Program, Roanoke, VA 24014, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Candelario","sequence":"additional","affiliation":[{"name":"Geriatric Research Group, Veterans Affairs Medical Center, Salem, VA 24153, USA"},{"name":"Emergency Department, Veterans Affairs Medical Center, Salem, VA 24153, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Boyle","sequence":"additional","affiliation":[{"name":"Attending Physician, Veterans Affairs Medical Ce.nter, Syracuse, NY 13210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonna","family":"Detweiler","sequence":"additional","affiliation":[{"name":"Geriatric Research Group, Veterans Affairs Medical Center, Salem, VA 24153, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Lutgens","sequence":"additional","affiliation":[{"name":"Geriatric Research Group, Veterans Affairs Medical Center, Salem, VA 24153, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,12,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1176\/appi.ajp.158.8.1227","article-title":"CSF norepinephrine concentrations in posttraumatic stress disorder","volume":"158","author":"Geracioti","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"ref_2","unstructured":"American Psychiatric Association (2015). Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association. [5th ed.]."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","article-title":"Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_5","unstructured":"National Comorbidity Survey NCS-R Appendix Tables: Table 1. Lifetime Prevalence of DSM-IV\/WMH-CIDI Disorders by Sex and Cohort. Table 2. Twelve-Month Prevalence of DSM-IV\/WMH-CIDI Disorders by Sex and Cohort. Available online: http:\/\/www.hcp.med.harvard.edu\/ncs\/publications.php."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/aje\/kwf187","article-title":"Post-Traumatic Stress Disorder and Chronic Fatigue Syndrome-like illness among Gulf War Veterans: A population-based survey of 30,000 Veterans","volume":"157","author":"Kang","year":"2003","journal-title":"Am. J. Epidemiol."},{"key":"ref_7","unstructured":"Gradus, J.L. Epidemiology of PTSD. PTSD: National Center for PTSD, Available online: http:\/\/www.ptsd.va.gov\/professional\/PTSD-overview\/epidemiological-facts-ptsd.asp."},{"key":"ref_8","first-page":"4","article-title":"Post-traumatic stress disorder: The burden to the individual and to society","volume":"61","author":"Kessler","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/archpsyc.55.7.626","article-title":"Trauma and posttraumatic stress disorder in the community: The 1996 Detroit Area Survey of Trauma","volume":"55","author":"Breslau","year":"1998","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/archpsyc.1995.03950240066012","article-title":"Post-traumatic stress disorder in the National Comorbidity Survey","volume":"48","author":"Kessler","year":"1995","journal-title":"Arch. Gen. Psyciatry"},{"key":"ref_11","unstructured":"(2003). VA\/DoD Clinical Practice Guidelines for the Management of Post Traumatic Stress Disorders, Available online: http:\/www.oqp.med.va.gov\/cpg\/PTSD\/PTSD_GOL.htm."},{"key":"ref_12","unstructured":"Morin, R. The Difficult Transition from Military to Civilian Life. Pew Research Center Social and Demographic Trends. Available online: http:\/\/www.pewsocialtrends.org\/2011\/12\/08\/the-difficult-transition-from-military-to-civilian-life."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/tmj.2011.0064","article-title":"Salem VAMC-US Army Fort Bragg Warrior Transition Clinic ele-Psychiatry Collaboration: 12- Month Clinic Prospective","volume":"18","author":"Detweiler","year":"2012","journal-title":"Telemed. E-Health"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.smrv.2007.08.008","article-title":"Disturbed sleep in post-traumatic stress disorder; secondary symptom or core feature?","volume":"12","author":"Spoormaker","year":"2008","journal-title":"Sleep Med. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1176\/ajp.152.1.110","article-title":"Sleep events among veterans with combat-related posttraumatic stress disorder","volume":"152","author":"Mellman","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1176\/ajp.152.11.1659","article-title":"Sleep disturbance and its relationship to psychiatric morbidity after Hurricane Andrew","volume":"152","author":"Mellman","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1939-0025.1975.tb01177.x","article-title":"Symptom development in Vietnam era veterans","volume":"45","author":"Rustin","year":"1975","journal-title":"Am. J. Orthopsychiatr."},{"key":"ref_18","first-page":"429","article-title":"Sleep disturbances in posttraumatic stress disorder: A comparison with non-PTSD insomnia","volume":"3","author":"Inman","year":"1990","journal-title":"J. Trauma. Stress"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3928\/00485713-20051101-04","article-title":"A new treatment algorithm for posttraumatic stress disorder","volume":"35","author":"Davidson","year":"2005","journal-title":"Psychiatr. Ann."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00004850-200607000-00001","article-title":"Pharmacotherapy for disordered sleep in post-traumatic stress disorder: A systematic review","volume":"21","author":"Vermetten","year":"2006","journal-title":"Int. Clin. Psychopharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.5664\/jcsm.27883","article-title":"Best Practice Guide for the Treatment of Nightmare Disorder in Adults. Standards of Practice Committee","volume":"6","author":"Aurora","year":"2010","journal-title":"J. Clin. Sleep Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1192\/bjp.175.1.17","article-title":"Fluoxetine in post-traumatic stress disorder. Randomized, double-blind study","volume":"175","author":"Connor","year":"1999","journal-title":"Br. J. Psychiatry"},{"key":"ref_23","first-page":"43","article-title":"Use of antipsychotics in the treatment of post-traumatic stress disorder","volume":"2","author":"Adetunji","year":"2000","journal-title":"Psychiatry"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/01.yic.0000185021.48279.00","article-title":"Aripiprazole in the management of post-traumatic stress disorder symptoms in returning Global War on Terrorism veterans","volume":"21","author":"Lambert","year":"2006","journal-title":"Int. Clin. Psychopharmacol."},{"key":"ref_25","unstructured":"Jeffreys, M. Clinician\u2019s Guide to Medications for PTSD. PTSD: National Center for PTSD, Available online: http:\/\/www.ptsd.va.gov\/professional\/treatment\/overview\/clinicians-guide-to-medications-for-ptsd.asp."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.biopsych.2006.06.032","article-title":"A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder","volume":"61","author":"Raskind","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"ref_27","first-page":"40","article-title":"When patients can\u2019t sleep: Practical guide to using and choosing hypnotic therapy","volume":"2","author":"Doghramji","year":"2003","journal-title":"Curr. Psychiatry"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.4088\/JCP.13m08592","article-title":"Do benzodiazepines reduce the effectiveness of exposure therapy for posttraumatic stress disorder?","volume":"74","author":"Rosen","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"892","DOI":"10.4088\/JCP.09m05607gry","article-title":"Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: A randomized, double-blind, placebo-controlled trial","volume":"72","author":"Pollack","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"ref_30","first-page":"60","article-title":"Topiramate in posttraumatic stress disorder: Preliminary Clinical observations","volume":"62","author":"Berlant","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4088\/JCP.v63n0104","article-title":"Open label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: A preliminary report","volume":"63","author":"Berlant","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"ref_32","first-page":"40","article-title":"Topiramate as a Therapy for Chronic Posttraumatic Stress Disorder","volume":"3","author":"Berlant","year":"2006","journal-title":"Psychiatry"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jpsychires.2007.05.006","article-title":"Effect of post-retrieval propranolol on psychophysiologic responding during subsequent script-driven traumatic imagery in post-traumatic stress disorder","volume":"42","author":"Brunet","year":"2008","journal-title":"J. Psychiatr. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.4088\/JCP.v64n1204","article-title":"Tiagabine for PTSD: A case series of 7 women","volume":"64","author":"Taylor","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/JCP.0b013e31802e5115","article-title":"The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder","volume":"27","author":"Davidson","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/j.1875-9114.1991.tb04299.x","article-title":"Buspirone in the Treatment of Posttraumatic Stress Disorder","volume":"11","author":"Wells","year":"1991","journal-title":"Pharmacotherapy"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/10401230109148960","article-title":"Gabapentin in PTSD: A retrospective, clinical series of adjunctive therapy","volume":"13","author":"Hamner","year":"2001","journal-title":"Ann. Clin. Psychiatry"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/archpsyc.1981.01780290074008","article-title":"Treatment of traumatic war neurosis with Phenelzine","volume":"38","author":"Hogben","year":"1981","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1001\/archpsyc.1987.01800230056010","article-title":"Posttraumatic stress disorder in Israeli combat veterans. Effect of phenelzine treatment","volume":"44","author":"Lerer","year":"1987","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1196\/annals.1364.016","article-title":"Glucocorticoid-induced inhibition of memory retrieval: Implications for posttraumatic stress disorder","volume":"1071","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ejphar.2007.11.068","article-title":"Glucocorticoids for the treatment of post-traumatic stress disorder and phobias: A novel therapeutic approach","volume":"583","author":"Margraf","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"ref_42","unstructured":"American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association. [4th ed.]."},{"key":"ref_43","unstructured":"American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association. [4th ed., text rev.]."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"565","DOI":"10.4088\/JCP.v63n0705","article-title":"Prazosin reduces nightmares in combat veterans with posttraumatic stress disorder","volume":"63","author":"Raskind","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4088\/JCP.v61n0208","article-title":"The alpha1-adrenergic antagonist prazosin ameliorates combat trauma nightmares in veterans with posttraumatic stress disorder: A report of 4 cases","volume":"61","author":"Raskind","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1176\/appi.ajp.160.2.371","article-title":"Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: A placebo-controlled study","volume":"160","author":"Raskind","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.biopsych.2007.07.001","article-title":"Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: A placebo-controlled study","volume":"63","author":"Taylor","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/00005053-199410000-00010","article-title":"The polysomnographic effects of clonidine on sleep disorders in posttraumatic stress disorder: A pilot study with Cambodian patients","volume":"182","author":"Kinzie","year":"1994","journal-title":"J. Nerv. Ment. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/milmed\/156.2.100","article-title":"Cyproheptadine for combat related nightmares in post traumatic stress disorder and dream anxiety disorder","volume":"156","author":"Brophy","year":"1991","journal-title":"Mil. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0010-440X(98)90076-1","article-title":"Efficacy of cyproheptadine for nightmares associated with posttraumatic stress disorder","volume":"39","author":"Gupta","year":"1998","journal-title":"Compr. Psychiatry"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1176\/appi.ajp.159.10.1777","article-title":"Adjunctive olanzapine for SSRI-resistant combat-related PTSD: A double-blind, placebo-controlled study","volume":"159","author":"Stein","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1176\/ps.49.2.245","article-title":"Risperidone in PTSD","volume":"49","author":"Leyba","year":"1998","journal-title":"Psychistr. Serv."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/01.jcp.0000169624.37819.60","article-title":"Quetiapine improves sleep disturbances in combat veterans with PTSD: Sleep data from a prospective, open-label study","volume":"25","author":"Robert","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1097\/00007611-199311000-00022","article-title":"Use of thioridazine in post-traumatic stress disorder","volume":"86","author":"Dillard","year":"1993","journal-title":"South. Med. J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00004850-199805000-00003","article-title":"Treatment of posttraumatic stress disorder with nefazodone","volume":"13","author":"Davidson","year":"1998","journal-title":"Int. Clin. Psychopharmacol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00004850-199903000-00001","article-title":"Nefazodone in post-traumatic stress disorder: Results from six open-label trials","volume":"14","author":"Hidalgo","year":"1999","journal-title":"Int. Clin. Psychopharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"789","DOI":"10.4088\/JCP.v62n1007","article-title":"An open-label, 12-week clinical and sleep EEG study of nefazodone in chronic combat-related posttraumatic stress disorder","volume":"62","author":"Gillin","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4088\/JCP.v64n0415","article-title":"The effect of nefazodone on subjective and objective sleep quality in posttraumatic stress disorder","volume":"64","author":"Neylan","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4088\/JCP.v61n0310","article-title":"Nefazodone in patients with treatment refractory posttraumatic stress disorder","volume":"61","author":"Zisook","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"460","DOI":"10.4088\/JCP.v59n0904","article-title":"Open trial of nefazodone for combat-related posttraumatic stress disorder","volume":"59","author":"Hertzberg","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1055\/s-2001-15871","article-title":"Survey on the usefulness of trazodone in patients with PTSD with insomnia or nightmares","volume":"34","author":"Warner","year":"2001","journal-title":"Pharmacopsychiatry"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/da.1082","article-title":"Fluvoxamine treatment in veterans with combat-related post-traumatic stress disorder","volume":"15","author":"Escalona","year":"2002","journal-title":"Depress. Anxiety"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1023\/A:1011100420978","article-title":"Fluvoxamine and sleep disturbances in posttraumatic stress disorder","volume":"14","author":"Neylan","year":"2001","journal-title":"J. Trauma. Stress"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000288593","article-title":"Fluvoxamine treatment for chronic PTSD: A pilot study","volume":"57","author":"Falger","year":"1992","journal-title":"Psychother. Psychosom."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/brb3.183","article-title":"A factor analysis of posttraumatic stress disorder symptoms using data pooled from two venlafaxine extended-release clinical trials","volume":"3","author":"Stein","year":"2013","journal-title":"Brain Behav."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00004850-200015040-00006","article-title":"Symptom-specific effects of fluoxetine in post-traumatic stress disorder","volume":"15","author":"Connor","year":"2000","journal-title":"Int. Clin. Psychopharmacol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4088\/JCP.v63n0305","article-title":"Fluoxetine versus placebo in posttraumatic stress disorder","volume":"63","author":"Martenyi","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"ref_68","first-page":"517","article-title":"Fluoxetine in posttraumatic stress disorder","volume":"55","author":"Dreyfuss","year":"1994","journal-title":"J. Clin. Psychiatry"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00005053-199106000-00011","article-title":"Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine","volume":"179","author":"Kosten","year":"1991","journal-title":"J. Nerv. Ment. Dis."},{"key":"ref_70","first-page":"956","article-title":"One year follow-up study of posttraumatic stress disorder among survivors of Cambodian concentration camps","volume":"42","author":"Boehnlein","year":"1985","journal-title":"Am. J. Psychiatry"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1345\/aph.1E043","article-title":"Clonazepam for treatment of sleep disturbances associated with combat-related posttraumatic stress disorder","volume":"38","author":"Cates","year":"2004","journal-title":"Ann. Pharmacother."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.4088\/JCP.v63n1214h","article-title":"Hypnotic medication in the aftermath of trauma","volume":"63","author":"Mellman","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"ref_73","first-page":"236","article-title":"Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment","volume":"51","author":"Braun","year":"1990","journal-title":"J. Clin. Psychiatry"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1600-0447.1983.tb00336.x","article-title":"Double-blind trial of triazolam 0.5 mg vs. nitrazepam 5 mg in outpatients","volume":"67","author":"Ellingsen","year":"1983","journal-title":"Acta Psychiatr. Scand."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1345\/aph.1H588","article-title":"Prazosin treatment of nightmares related to posttraumatic stress disorder","volume":"41","author":"Dierks","year":"2007","journal-title":"Ann. Pharmacother."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.biopsych.2007.02.020","article-title":"The use of prazosin for the treatment of trauma nightmares and sleep disturbances in combat veterans with PTSD","volume":"61","author":"Krystal","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"ref_77","unstructured":"Prazosin Side Effects. Available online: http:\/\/www.drugs.com\/sfx\/prazosin-side-effects.html."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/2045125313500982","article-title":"High-dose prazosin for the treatment of post-traumatic stress disorder","volume":"4","author":"Koola","year":"2014","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1176\/appi.ajp.2013.12081133","article-title":"A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan","volume":"170","author":"Raskind","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00004714-200202000-00013","article-title":"The alpha1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder","volume":"22","author":"Taylor","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/0891988703256050","article-title":"Prazosin reduces trauma-related nightmares in older men with chronic posttraumatic stress disorder","volume":"16","author":"Peskind","year":"2003","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/00005053-198909000-00005","article-title":"Clonidine in Cambodian patients with posttraumatic stress disorder","volume":"177","author":"Kinzie","year":"1989","journal-title":"J. Nerv. Ment. Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1440-1819.2003.01207.x","article-title":"Clonidine effects on all-night human sleep: Opposite action of low- and medium-dose clonidine on human NREM-REM sleep proportion","volume":"58","author":"Miyazaki","year":"2004","journal-title":"Psychiatry Clin. Neurosci."},{"key":"ref_84","unstructured":"Gore, T.A., Lucas, J.Z., Talavera, F., and Ahmed, I. Posttraumatic Stress Disorder Medication. Available online: http:\/\/emedicine.medscape.com\/article\/288154-medication."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1186\/1744-859X-5-S1-S159","article-title":"Effect of cyproheptadine on combat related PTSD nightmares","volume":"5","author":"Ahmadzadeh","year":"2006","journal-title":"Ann. Gen. Psychiatry"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1176\/appi.ajp.157.9.1525","article-title":"Posttraumatic stress disorder and sleep difficulty","volume":"157","author":"Schnurr","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1023\/B:ACLI.0000008173.01153.4e","article-title":"Pharmacologic Treatment of Posttraumatic Stress disorder. A focus on Antipsychotic Use","volume":"15","author":"Ahearn","year":"2003","journal-title":"Ann. Clin. Psychiatry"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1097\/00004714-200304000-00012","article-title":"Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder","volume":"23","author":"Monnelly","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_89","first-page":"1","article-title":"Adjunctive Risperidone treatment in post-traumatic stress disorder: A preliminary controlled trial of effects on comorbid psychotic symptoms","volume":"18","author":"Hammer","year":"2003","journal-title":"Int. Clin. Psychopharmacol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.4088\/JCP.v65n1204","article-title":"A preliminary study of risperidone in the treatment of posttraumatic stress disorder related to childhood abuse in women","volume":"65","author":"Reich","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/da.20187","article-title":"Adjunctive Risperidone treatment and sleep symptoms in combat veterans with chronic PTSD","volume":"23","author":"David","year":"2006","journal-title":"Depress. Anxiety"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00004630-200105000-00005","article-title":"The Effectiveness of Risperidone on Acute Stress Symptoms in Adult Burn Patients: A Preliminary Retrospective Pilot Study","volume":"22","author":"Stanovic","year":"2001","journal-title":"J. Burn Care Rehabil."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00004850-200107000-00003","article-title":"Olanzapine in the treatment of post-traumatic stress disorder: A pilot study","volume":"1","author":"Butterfield","year":"2001","journal-title":"Int. Clin. Psychopharmacol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/jama.2011.1080","article-title":"Veterans Affairs Cooperative Study No. 504 Group. Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: A randomized trial","volume":"306","author":"Krystal","year":"2011","journal-title":"JAMA"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/JCP.0b013e3181faa597","article-title":"Risperidone for nightmares of combat veterans: Case series","volume":"30","author":"Khachiyants","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"920","DOI":"10.4140\/TCP.n.2011.920","article-title":"Risperidone for nightmares of combat veterans: Four cases","volume":"26","author":"Detweiler","year":"2011","journal-title":"Consult. Pharm."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","article-title":"Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding","volume":"124","author":"Schotte","year":"1996","journal-title":"Psychopharmacology"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"922","DOI":"10.4088\/JCP.v66n0716","article-title":"Risperidone in Psychotic Combat-Related Posttraumatic Stress Disorder: An Open Trial","volume":"66","author":"Pivac","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Richardson, J.D., Fikretoglu, D., Liu, A., and McIntosh, D. (2011). Aripiprazole augmentation in the treatment of military-related PTSD with major depression: A retrospective chart review. BMC Psychiatry, 17.","DOI":"10.1186\/1471-244X-11-86"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1590\/S1516-44462008000400011","article-title":"Aripiprazole in the treatment of posttraumatic stress disorder: An open-label trial","volume":"30","author":"Mello","year":"2008","journal-title":"Rev. Bras. Psiquiatr."},{"key":"ref_101","first-page":"617","article-title":"Post-traumatic psychoneurosis: Evaluation of drug therapy","volume":"38","author":"Thompson","year":"1977","journal-title":"Dis. Nerv. Syst."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00004714-199608000-00004","article-title":"Trial of trazodone for posttraumatic stress disorder using a multiple baseline group design","volume":"16","author":"Hertzberg","year":"1996","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF02307588","article-title":"Effects of trazodone on sleep in patients diagnosed with Post-Traumatic Stress Disorder (PTSD)","volume":"26","author":"Ashford","year":"1996","journal-title":"J. Contemp. Psychother."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0006-3223(02)01411-7","article-title":"Mirtazapine vs. placebo in posttraumatic stress disorder: A pilot trial","volume":"53","author":"Davidson","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1176\/appi.ajp.159.11.1948-a","article-title":"Mirtazapine for PTSD nightmares","volume":"159","author":"Lewis","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-2125.2008.03305.x","article-title":"Mirtazapine induced nightmares in an adult male","volume":"67","author":"Dang","year":"2009","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_107","unstructured":"VA Office of Research and Development, VA Office of Research and Development, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00302107."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/01.jcp.0000125685.82219.1a","article-title":"A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: A preliminary study","volume":"24","author":"Davis","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/(SICI)1520-6394(1999)9:3<146::AID-DA9>3.0.CO;2-Y","article-title":"Nefazodone treatment and dream reports in chronic PTSD","volume":"9","author":"Mellman","year":"1999","journal-title":"Depress. Anxiety"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/10401230209147460","article-title":"Three- to four-year follow-up to an open trial of nefazodone for combat-related posttraumatic stress disorder","volume":"14","author":"Hertzberg","year":"2002","journal-title":"Ann. Clin. Psychiatry"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/jama.283.14.1837","article-title":"Efficacy and safety of sertraline treatment of posttraumatic stress disorder: A randomized controlled trial","volume":"283","author":"Brady","year":"2000","journal-title":"JAMA"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4088\/JCP.v62n0503","article-title":"Sertraline treatment of posttraumatic stress disorder: Results of 24 weeks of open-label continuation treatment","volume":"62","author":"Londborg","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/archpsyc.58.5.485","article-title":"Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder","volume":"58","author":"Davidson","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1001\/archpsyc.1990.01810150059010","article-title":"Treatment of posttraumatic stress disorder with amitriptyline and placebo","volume":"47","author":"Davidson","year":"1990","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1176\/ajp.145.10.1289","article-title":"A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder","volume":"145","author":"Frank","year":"1988","journal-title":"Am. J. Psychiatry"},{"key":"ref_116","first-page":"16","article-title":"Posttraumatic Stress Disorder and Benzodiazepines: A Myth Agreed Upon","volume":"27","author":"Roth","year":"2010","journal-title":"Fed. Pract."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Geuze1, E., van Berckel, B.N.M., Lammertsma, A.A., Boellaard, R., de Kloet, C.S., Vermetten, E., and Westenberg, H.G.M. (2008). Reduced GABAA benzodiazepine receptor binding in veterans with post-traumatic stress disorder. Mol. Psychiatry, 13, 74\u201383.","DOI":"10.1038\/sj.mp.4002054"},{"key":"ref_118","first-page":"390","article-title":"Treatment of recent trauma survivors with benzodiazepines: A prospective study","volume":"57","author":"Gelpin","year":"1996","journal-title":"J. Clin. Psychiatry"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1176\/appi.ajp.159.10.1696","article-title":"REM Sleep and the Early Development of Posttraumatic Stress Disorder","volume":"159","author":"Mellman","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1176\/appi.ps.201200217","article-title":"Aligning clinical practice to PTSD treatment guidelines: Medication prescribing by provider type","volume":"64","author":"Abrams","year":"2013","journal-title":"Psychiatr. Serv."},{"key":"ref_121","first-page":"1","article-title":"The Role of Benzodiazepines in the Treatment of Posttraumatic Stress Disorder (PTSD)","volume":"23","author":"Bernardy","year":"2013","journal-title":"PTSD Res. Q."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.drugalcdep.2012.01.003","article-title":"Prevalence and trends of benzodiazepine use among Veterans Affairs patients with posttraumatic stress disorder, 2003\u20132010","volume":"124","author":"Hawkins","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4088\/JCP.v62n0603","article-title":"Efficay and Safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: An open-label trial","volume":"62","author":"Fava","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"ref_124","first-page":"441","article-title":"Eszoplicone: Its use in the treatment of insomnia","volume":"3","author":"Monti","year":"2007","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1176\/ps.50.3.421","article-title":"Zolpidem for insomnia related to PTSD","volume":"50","author":"Dieperink","year":"1999","journal-title":"Psychiatr. Serv."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.0003-2409.2001.02399.x","article-title":"Gabapentin: Pharmacology and its use in pain management","volume":"57","author":"Rose","year":"2002","journal-title":"Anaesthesia"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1213\/01.ane.0000287643.13410.5e","article-title":"Pregabalin: Its pharmacology and use in pain management","volume":"105","author":"Gajraj","year":"2007","journal-title":"Anesth. Analg."},{"key":"ref_128","first-page":"433","article-title":"Tiagabine is Associated With Sustained Attention During Sleep Restriction: Evidence for the Value of Slow-Wave Sleep Enhancement?","volume":"29","author":"Walsh","year":"2006","journal-title":"Sleep"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1176\/appi.ajp.161.8.1488","article-title":"Low-dose cortisol for symptoms of posttraumatic stress disorder","volume":"161","author":"Aerni","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"ref_130","unstructured":"Jancin, B. Venlafaxine Becomes First-Line PTSD Therapy in Latest VA Guidelines. Available online: http:\/\/www.internalmedicinenews.com\/index.php?id=495&tx_ttnews[tt_news]=52779&tx_ttnews[sViewPointer]=2&cHash=0b6e7e1b598f7d238a11582beb68f3c1."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/5\/12\/117\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:28:41Z","timestamp":1760210921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/5\/12\/117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,16]]},"references-count":130,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12]]}},"alternative-id":["jcm5120117"],"URL":"https:\/\/doi.org\/10.3390\/jcm5120117","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,16]]}}}